127 related articles for article (PubMed ID: 38872584)
1. Treatment of actinic prurigo with dupilumab in an adolescent.
Shah A; Mittal S; Tollefson MM; Davis DM; Mohandesi NA
Int J Dermatol; 2024 Jun; ():. PubMed ID: 38872584
[No Abstract] [Full Text] [Related]
2. Clearance of pediatric actinic prurigo with dupilumab.
Eickstaedt JB; Starke S; Krakora D; Hinshaw M; Arkin LM
Pediatr Dermatol; 2020 Nov; 37(6):1176-1178. PubMed ID: 32869345
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab as treatment of actinic prurigo suggests pathophysiologic mechanism of disease: A case series.
Barker CS; Sattele L; Strat N; Daniel S; Snyder A; Siegel M; Wine Lee L
JAAD Case Rep; 2024 Apr; 46():89-91. PubMed ID: 38577500
[No Abstract] [Full Text] [Related]
4. Actinic prurigo in a dermatological reference center in Colombia: 108 cases.
Pardo-Zamudio AC; Valbuena MC; Jiménez-Torres HD; Colmenares-Mejía CC
Biomedica; 2020 Sep; 40(3):487-497. PubMed ID: 33030827
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab for prurigo nodularis: Case series and review of the literature.
Holm JG; Agner T; Sand C; Thomsen SF
Dermatol Ther; 2020 Mar; 33(2):e13222. PubMed ID: 31917498
[TBL] [Abstract][Full Text] [Related]
6. Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
Takeuchi S; Inoue K; Kuretake K; Kiyomatsu-Oda M; Furue M
J Dermatol; 2021 May; 48(5):638-644. PubMed ID: 33742710
[TBL] [Abstract][Full Text] [Related]
7. A critical review of dupilumab for adult patients with prurigo nodularis.
Biazus Soares G; Yosipovitch G
Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab for the treatment of prurigo nodularis: A systematic review.
Cao P; Xu W; Jiang S; Zhang L
Front Immunol; 2023; 14():1092685. PubMed ID: 36742321
[TBL] [Abstract][Full Text] [Related]
9. Successful thalidomide therapy for actinic prurigo in a European woman.
Holzer A; Wolf P; Legat FJ; Kerl H; Hofer A
J Dtsch Dermatol Ges; 2006 Nov; 4(11):961-4. PubMed ID: 17081272
[TBL] [Abstract][Full Text] [Related]
10. Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life.
Richter C; Hafner J; Schuermann M; Tanadini M; Trisconi N; Schmid-Grendelmeier P; Kündig T; Nägeli M; Brüggen MC; Guillet C
Dermatology; 2023; 239(5):811-817. PubMed ID: 37369187
[TBL] [Abstract][Full Text] [Related]
11. Dupilumab for the Treatment of Prurigo Nodularis.
Alkhaleefa A; Woo TE; Parsons L
Skin Therapy Lett; 2023 Nov; 28(6):7-9. PubMed ID: 38016088
[TBL] [Abstract][Full Text] [Related]
12. Actinic prurigo of the lip: Two case reports.
Miranda AM; Ferrari TM; Werneck JT; Junior AS; Cunha KS; Dias EP
World J Clin Cases; 2014 Aug; 2(8):385-90. PubMed ID: 25133153
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Husein-ElAhmed H; Steinhoff M
J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subtypes and adhesion molecules in actinic prurigo: observations with cyclosporin A.
Umaña A; Gómez A; Durán MM; Porras L
Int J Dermatol; 2002 Mar; 41(3):139-45. PubMed ID: 12010338
[TBL] [Abstract][Full Text] [Related]
15. Treatment of actinic prurigo in Chimila Indians.
Durán MM; Ordoñez CP; Prieto JC; Bernal J
Int J Dermatol; 1996 Jun; 35(6):413-6. PubMed ID: 8737876
[TBL] [Abstract][Full Text] [Related]
16. A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis.
Zhang Z; Li S; Wang Y; Zhao J
An Bras Dermatol; 2023; 98(4):440-448. PubMed ID: 36966024
[TBL] [Abstract][Full Text] [Related]
17. Correlation of serum IgE levels and clinical manifestations in patients with actinic prurigo.
Cuevas-Gonzalez JC; Lievanos-Estrada Z; Vega-Memije ME; Hojyo-Tomoka MT; Dominguez-Soto L
An Bras Dermatol; 2016; 91(1):23-6. PubMed ID: 26982774
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of UV-induced skin lesions in actinic prurigo. Resistance of langerhans cells to UV light.
Torres-Alvarez B; Baranda L; Fuentes C; Delgado C; Santos-Martinez L; Portales-Perez D; Moncada B; Gonzalez-Amaro R
Eur J Dermatol; 1998; 8(1):24-8. PubMed ID: 9649710
[TBL] [Abstract][Full Text] [Related]
19. [T and B clonal populations in actinic prurigo, a photodermatosis].
González-Rodríguez G; Ocádiz-Delgado R
Gac Med Mex; 2001; 137(1):15-20. PubMed ID: 11244824
[TBL] [Abstract][Full Text] [Related]
20. Dupilumab for pediatric prurigo nodularis: A case report.
Fachler T; Maria Faitataziadou S; Molho-Pessach V
Pediatr Dermatol; 2021 Jan; 38(1):334-335. PubMed ID: 33247435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
